Liver Endothelium Promotes HER3-Mediated Cell Survival in Colorectal Cancer with Wild-Type and Mutant KRAS.

Moeez RathoreWei ZhangMichel'le WrightRajat BhattacharyaFan FanAli Vaziri-GoharJordan WinterZhenghe WangSanford D MarkowitzJoseph WillisLee M EllisRui Wang

Published in: Molecular cancer research : MCR (2022)

This body of work highlighted a potential strategy of using HER3 antibodies in combination with standard chemotherapy agents for treating patients with either KRAS wild-type or KRAS mutant metastatic colorectal cancer.

Keyphrases

wild type
metastatic colorectal cancer
nitric oxide
squamous cell carcinoma
climate change
chemotherapy induced